Psychologists in Naguabo, PR Accepting Medicare
6 Psychologists found. Showing 1 - 6
 Eduardo Lopez, PSYCHOLOGYST Psychologist Medicare: Not Enrolled in Medicare Practice Location: Urb Diplo Calle 11 E-27, Naguabo, PR 00718 Phone: 787-874-2624 |
 Omayra J Ramos, MA. Psychologist - Counseling Medicare: Not Enrolled in Medicare Practice Location: Bo. Cecilia, Carr. 31, Naguabo, PR 00718 Phone: 787-316-6295 |
Tatiana Marie Perez, M.A Psychologist - Counseling Medicare: Not Enrolled in Medicare Practice Location: 55 Calle 5, Juan B Mendoza, Naguabo, PR 00718 Phone: 787-409-3188 |
Mrs. Keila B Ortiz, MA PSYC Psychologist - School Medicare: Not Enrolled in Medicare Practice Location: Urb. Diplo, Calle 18 Q 36, Naguabo, PR 00718 Phone: 787-597-0826 |
Mrs. Maritza Rodriguez Psychologist Medicare: Not Enrolled in Medicare Practice Location: 33 Calle Celis Aguilera, Naguabo, PR 00718 Phone: 787-906-4903 |
Mrs. Maria M Ramos, MA Psychologist Medicare: Not Enrolled in Medicare Practice Location: 33 Calle Celis Aguilera, Detras Del Banco Popular, Naguabo, PR 00718 Phone: 787-400-0456 |
News Archive
Fluorescent nanoparticles open up new possibilities for cellular imaging
Scientists from the University of Twente, the Netherlands, have successfully exploited the optical properties of fluorescent nanoparticles to broaden the scope of single-cell microscopy.
Taiho announces results of TAS-102 Phase II trial for metastatic colorectal cancer
Taiho Pharmaceutical Co., Ltd. announced on July 22 the results of a randomized, Phase II clinical trial for the novel oral nucleoside antitumor agent TAS-102 under development by the company for metastatic colorectal cancer, at the 9th Annual Meeting of the Japanese Society of Medical Oncology held in Yokohama.
Findings could help athletic departments better prepare athletes for NFL combine test
Athletic performance varies from day to day, which can make it difficult for strength and conditioning professionals to judge whether athletes' improvements are due to effective training.
OncoSec establishes UCSF as second enrolling site for OMS-I110 Phase II Merkel cell carcinoma trial
OncoSec Medical Inc., a company developing the advanced-stage OncoSec Medical System (OMS) ElectroOncology therapies to treat solid tumors, announces it has established the University of California San Francisco (UCSF) as the second enrolling site for its Phase II Merkel cell carcinoma clinical trial (OMS-I110).
Jeffrey Modell Foundation opens new center for primary immunodeficiency
The Jeffrey Modell Foundation today announced the opening of a new center at Johns Hopkins Children's Center dedicated to the early diagnosis and appropriate treatment of children with primary immunodeficiency, a group of potentially fatal conditions in which the immune system malfunctions or is missing.
› Verified 7 days ago
Pharmacists
Psychologists
Dentists
Clinical Social Workers
Counselors
Occupational Therapists